Suppr超能文献

通过新型 BaseScope 原位杂交检测 FOXL2 C134W 突变状态对成人颗粒细胞瘤具有高度的敏感性和特异性。

Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.

机构信息

Department of Pathology, Stanford University School of Medicine, Stanford, California.

Department of Pathology, Stanford University School of Medicine, Stanford, California; Meharry Medical College, School of Medicine, Nashville, Tennessee.

出版信息

Mod Pathol. 2023 Nov;36(11):100318. doi: 10.1016/j.modpat.2023.100318. Epub 2023 Aug 25.

Abstract

Adult granulosa cell tumors (AGCTs) are a molecularly distinct group of malignant ovarian sex cord-stromal tumors (SCSTs) characterized by a nearly ubiquitous c.402C>G/p.C134W mutation in FOXL2 (hereafter referred to as "C134W"). In some cases, AGCT exhibits marked morphologic overlap with other SCSTs and has an identical immunophenotype, and molecular testing may be necessary to help confirm the diagnosis. However, molecular testing is time consuming, relatively expensive, and unavailable in many pathology laboratories. We describe the development and validation of an in situ hybridization (ISH) custom BaseScope assay for the detection of the FOXL2 C134W mutation. We evaluated 106 ovarian SCSTs, including 78 AGCTs, 9 juvenile granulosa cell tumors, 18 fibromas (cellular and conventional), and 1 SCST, not otherwise specified, as well as 53 epithelial ovarian tumors (42 endometrioid carcinomas and 11 carcinosarcomas) and 1 STK11 adnexal tumor for the presence or absence of FOXL2 wild-type and FOXL2 C134W RNA expression via BaseScope-ISH. Fifty-one tumors had previously undergone DNA sequencing of the FOXL2 gene. Across the entire cohort, the FOXL2 C134W probe staining was positive in 77 of 78 (98.7%) AGCTs. Two of 81 (2.5%) non-AGCTs also showed positive staining, both of which were epithelial ovarian tumors. The assay worked in tissue from blocks >20 years old. There was 100% concordance between the FOXL2 sequencing and BaseScope-ISH results. Overall, assessment of FOXL2 mutation status by custom BaseScope-ISH demonstrated 98.7% sensitivity and 97.5% specificity for the diagnosis of AGCT. BaseScope-ISH for FOXL2 C134W represents a reasonable alternative to sequencing, is quicker and less expensive, and is more easily incorporated than molecular testing into many pathology laboratories. It also has the advantage of requiring less tissue, and the neoplastic cells can be directly visualized on stained sections.

摘要

成人颗粒细胞瘤(AGCT)是一种具有独特分子特征的恶性卵巢性索-间质肿瘤(SCST),其特征是 FOXL2 中几乎普遍存在的 c.402C>G/p.C134W 突变(以下简称“C134W”)。在某些情况下,AGCT 与其他 SCST 具有明显的形态学重叠,且具有相同的免疫表型,可能需要进行分子检测以帮助确认诊断。然而,分子检测耗时、相对昂贵,且在许多病理实验室中不可用。我们描述了一种用于检测 FOXL2 C134W 突变的原位杂交(ISH)定制 BaseScope 检测的开发和验证。我们评估了 106 例卵巢性索-间质肿瘤,包括 78 例 AGCT、9 例幼年颗粒细胞瘤、18 例纤维瘤(细胞性和普通性)和 1 例未特指的性索-间质肿瘤,以及 53 例上皮性卵巢肿瘤(42 例子宫内膜样癌和 11 例癌肉瘤)和 1 例 STK11 附件肿瘤,通过 BaseScope-ISH 检测 FOXL2 野生型和 FOXL2 C134W RNA 表达的存在或缺失。51 例肿瘤先前已进行 FOXL2 基因的 DNA 测序。在整个队列中,78 例 AGCT 中有 77 例(98.7%)FOXL2 C134W 探针染色阳性。81 例非 AGCT 中有 2 例(2.5%)也显示阳性染色,均为上皮性卵巢肿瘤。该检测在超过 20 年的旧组织块中仍能正常工作。FOXL2 测序和 BaseScope-ISH 结果之间具有 100%的一致性。总体而言,通过定制 BaseScope-ISH 评估 FOXL2 突变状态对 AGCT 的诊断具有 98.7%的敏感性和 97.5%的特异性。FOXL2 C134W 的 BaseScope-ISH 代表了测序的合理替代方法,它更快、更便宜,且比分子检测更容易纳入许多病理实验室。它还具有需要更少组织的优势,并且可以直接在染色切片上观察到肿瘤细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验